Table 2.
Categorical demographic characteristics and indicators of HCV management, treatment, and outcomes according to Aboriginal status.
| Categorical variables | Aboriginal status | p value | |
|---|---|---|---|
| Aboriginal (n = 55) | Non-Aboriginal (n = 1923) | ||
| Underwent biopsy | 44.4 | 48.9 | 0.517 |
| Underwent Fibroscan | 13.0 | 15.3 | 0.64 |
| Initiated HCV antiviral therapy | 37.0 | 40.8 | 0.574 |
| Use of erythropoietin | 0.0 | 6.4 | 0.054 |
| Treatment type | 0.262 | ||
| Naive | 63.0 | 60.7 | |
| Interferon based | 37.0 | 34.5 | |
| DAA ± IFN | 0.0 | 4.7 | |
| Treatment status | 0.001 | ||
| Treatment failure | 10.0 | 13.3 | |
| Side effects/adverse event | 25.0 | 21.3 | |
| Adherence/substance abuse/lack of follow-up | 25.0 | 4.6 | |
| Completed treatment | 40.0 | 60.9 | |
|
| |||
| Achieved SVR | 56.3 | 58.9 | 0.833 |
| Achieved SVR by genotype | |||
| G1 | 60.0 | 54.3 | 0.720 |
| G2 | 0.0 | 82.6 | 0.035 |
| G3 | 75.0 | 66.4 | 0.720 |
| G4 | — | 32.4 | — |
| G5 | — | 100.0 | — |
| G6 | — | 77.8 | — |
The results represent “%”.